Management of Hyperglycemia in Type 1 Diabetes with Bacteremia

Immediate Management Strategy

The American Diabetes Association recommends maintaining the insulin drip as the primary glycemic control method during acute illness with bacteremia, as continuous IV insulin remains the therapy of choice for critically ill or severely hyperglycemic patients with type 1 diabetes 2
The American College of Clinical Endocrinologists suggests continuing the current 25 units of Lantus to provide basal coverage and facilitate eventual transition off the drip once the infection resolves 3
The Endocrine Society states that the overlap of IV insulin and subcutaneous basal insulin is appropriate and prevents rebound hyperglycemia when transitioning 4

Bacteremia causes significant insulin resistance through inflammatory cytokines and counter-regulatory hormone release, which explains why the blood glucose elevated despite appropriate carbohydrate ratio coverage, according to the American Association of Clinical Endocrinologists 1
The Infectious Diseases Society of America recommends increasing the insulin drip rate aggressively using a protocol-driven approach to achieve target blood glucose of 140-180 mg/dL for non-critically ill patients or 100-180 mg/dL if critically ill 5, 1

The Society of Critical Care Medicine suggests using a validated insulin infusion protocol with frequent blood glucose monitoring every 1-2 hours until stable, then every 2-4 hours 6, 3
The American Diabetes Association states that insulin requirements are expected to be 2-3 times higher than baseline during bacteremia due to stress-induced insulin resistance 7, 1

The Endocrine Society recommends increasing the insulin-to-carbohydrate ratio from 1:7 to 1:5 or even 1:4 during active infection to account for insulin resistance 1
The American Association of Clinical Endocrinologists suggests using correction doses of rapid-acting insulin every 4-6 hours in addition to meal coverage 1, 2

The American College of Clinical Endocrinologists recommends continuing the insulin drip until the bacteremia resolves and blood glucose stabilizes below 200 mg/dL on subcutaneous insulin alone 3, 4
The Society of Critical Care Medicine states that maintaining overlap between IV insulin and subcutaneous basal insulin for 1-3 hours when transitioning prevents rebound hyperglycemia 4

The American Diabetes Association explicitly recommends not using sliding scale insulin alone for type 1 diabetes, as this will result in inadequate glycemic control 5, 1, 2
The Endocrine Society states that never stopping Lantus in a type 1 diabetic patient, even during acute illness, is crucial to prevent diabetic ketoacidosis within hours 2, 9

The Infectious Diseases Society of America emphasizes that the primary intervention is appropriate antibiotic therapy for the bacteremia, as insulin resistance will persist until the infection resolves 1
The American Association of Clinical Endocrinologists recommends source control and adequate antimicrobial coverage to restore normal insulin sensitivity 7
The American College of Clinical Endocrinologists expects insulin requirements to decrease by 50% or more once the infection is treated 1